Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -36,648 | -26,912 | -12,449 | -44,099 |
| Depreciation Amortization | 1,754 | 1,139 | 563 | 2,091 |
| Accounts receivable | -3,060 | -4,556 | -1,918 | N/A |
| Accounts payable and accrued liabilities | 1,576 | 1,470 | 410 | N/A |
| Other Working Capital | -9,272 | -7,567 | -4,881 | -5,305 |
| Other Operating Activity | 11,656 | 12,045 | 6,131 | 14,868 |
| Operating Cash Flow | $-33,994 | $-24,381 | $-12,144 | $-32,445 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 28,970 | 11,807 | 8,000 | N/A |
| PPE Investments | -2,784 | -863 | -356 | -398 |
| Other Investing Activity | 0 | 0 | 0 | -69,295 |
| Investing Cash Flow | $26,186 | $10,944 | $7,644 | $-69,693 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 64 | 18 | 6 | N/A |
| Other Financing Activity | -1,341 | -119 | 0 | 101,029 |
| Financing Cash Flow | $-1,277 | $-101 | $6 | $101,029 |
| Beginning Cash Position | 26,666 | 26,667 | 26,666 | 27,775 |
| End Cash Position | 17,581 | 13,129 | 22,172 | 26,666 |
| Net Cash Flow | $-9,085 | $-13,538 | $-4,494 | $-1,109 |
| Free Cash Flow | ||||
| Operating Cash Flow | -33,994 | -24,381 | -12,144 | -32,445 |
| Capital Expenditure | -2,834 | -913 | -406 | N/A |
| Free Cash Flow | -36,828 | -25,294 | -12,550 | -32,445 |